Geisinger Health System
Freenome Partners With Geisinger to Recruit Patients for Multi-Cancer Screening Study
The Pennsylvania health system will be able to access patients in both urban and rural settings, aiding Freenome's goal to recruit a total of 8,000 individuals.
Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool
The proposed "High Impact Phenotype Identification System" aims to reduce time to diagnosis of 13 high-impact genetic conditions.
SARS-CoV-2 Pandemic A Test Case for Role of Lab Data in Population Health
A number of labs and informatics firms are using test data to help guide the response to the virus in a spirit similar to that of initiatives like Lab 2.0.
The firm looks to win new customers among US providers while also partnering with IVD companies to embed its lab data analysis tools in their instruments.
Smartphone-Based Kidney Disease Test 510(k) Cleared, Healthy.io Raises $60M
The firm said the clearance authorizes use of its smartphone-based albumin-to-creatinine ratio test by healthcare professionals at the point of care.
Jun 15, 2018